NEW YORK (GenomeWeb News) – Tute Genomics said this week that it has raised $1.5 million in a seed round of funding to advance its genome analysis software.

The company also said that it raised an additional $300,000 from AngelList, a fundraising platform for startups, through its new syndicate mechanism.

Investors in the seed round included Wilmington Pharmatech, Salt Lake Life Science Angels, Peak Ventures, Park City Angel Network, and individual angel investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.